Equistro respadril 5 vials 10 ml aerosol

DEADLINE 06/30/2025

Equistro Respadril is an aerosol specifically formulated for horses, indicated for the treatment of inflammatory and allergic respiratory conditions. Each pack contains 5 vials of 10 ml, ready to use to facilitate administration and ensure precise and controlled dosing.

The formulation of Equistro Respadril promotes the rapid and long-lasting relief of respiratory disorders in horses, improving their well-being and performance. The product is designed to be administered directly via aerosol, allowing a localized and targeted action on the respiratory tract.

The ease of use and effectiveness of the product make it an ideal choice for owners and veterinarians who wish to improve the quality of their horse's breathing, especially in conditions of acute or chronic respiratory stress.

Therapeutic Indications

Equistro Respadril is indicated for the treatment of various respiratory pathologies in horses, including allergic bronchitis, tracheitis, and inflammation of the upper and lower airways. The aerosol is particularly useful for alleviating symptoms associated with conditions such as equine asthma and chronic obstructive pulmonary disease, conditions which can significantly impair the breathing and athletic performance of animals.

The product works by reducing inflammation of the respiratory mucosa and facilitating the elimination of accumulated mucus, thus improving air flow and lung function. It is also indicated to aid recovery from acute respiratory infections, in association with antibiotic therapy or other appropriate veterinary therapies.

It can be used both as an emergency treatment for respiratory crises and as a long-term supportive therapy to prevent recurrences or worsening of chronic respiratory conditions. Regular administration, according to the veterinarian's instructions, helps to keep the airways free and ensure an adequate supply of oxygen during exercise and rest.

Composition

Active ingredient: Each 10 ml aerosol vial contains a balanced combination of active ingredients specifically chosen for their anti-inflammatory and bronchodilator effect. The ingredients are formulated to ensure safety and tolerability for use on horses, complying with the requirements for inhaled veterinary drugs.

The excipients present in the formulation facilitate the delivery of the drug in the form of a fine and uniform aerosol, ensuring homogeneous distribution along the respiratory system. The composition is free of irritating substances and suitable for regular use even in sensitive subjects or with chronic respiratory conditions.

The product is packaged in 10 ml single-dose vials, sterile and sealed, to maintain the integrity and effectiveness of the drug until use. The quality of the ingredients and the precision of the composition ensure an effective and safe treatment for the horse.

Contraindications

Do not use Equistro Respadril in case of known hypersensitivity to one or more components of the formulation. Its use is not recommended in horses with serious viral infections or in subjects with particularly compromised systemic conditions, unless otherwise indicated by the veterinarian.

The aerosol is not indicated as the sole treatment in cases of serious bacterial infections or extensive pneumonia, where specific integrative therapy is necessary. It is important to always contact a veterinarian before starting treatment to evaluate the correct diagnosis and the most suitable treatment plan.

In case of suspected adverse reactions, such as persistent respiratory irritation or worsening of symptoms, it is recommended to discontinue use and immediately consult your veterinarian for further evaluation.

Safety of the drug for the species

Equistro Respadril was formulated with the safety of horses in mind, with studies demonstrating its tolerability even in repeated administrations. The presence of the active ingredient in aerosolized form ensures rapid localized action with minimal systemic effects, reducing risks and contraindications.

However, it is important to follow the veterinary instructions regarding the dosage and frequency of administration, avoiding administration in excess or too close together which could cause irritation or side effects.

To minimize risks, the aerosol must be administered with appropriate systems and in well-ventilated environments, to ensure that inhalation is targeted and does not cause discomfort to either the animal or the operators. Correct use promotes effective management of respiratory pathologies without compromising the general well-being of the horse.

Precautions

When using Equistro Respadril, some specific precautions must be taken. It is essential that administration takes place under the supervision of a veterinarian, especially in prolonged treatments or in the case of particularly delicate chronic respiratory pathologies.

The product must be kept out of reach of children and pets who are not recipients of the treatment. It is important to avoid direct exposure of operators to the aerosol jet which could cause irritation or allergic reactions.

During administration, it is advisable to carefully monitor the horse for any signs of discomfort or adverse reactions and, if in doubt, to discontinue use immediately and consult your veterinarian. Furthermore, it is recommended to respect the storage conditions indicated on the packaging to maintain the effectiveness of the product.

Method of administration

Equistro Respadril is administered by inhalation via aerosolization of single-dose vials. It is important to use a nebulizer or a special device that allows a fine and controlled diffusion of the drug, so as to effectively reach the horse's airways.

The procedure involves the use of a single vial for each treatment, administered calmly and carefully to encourage deep inhalation. It is advisable to carry out administration in a quiet environment to reduce the animal's stress and improve therapeutic efficacy.

The frequency and duration of treatment should be determined by the veterinarian based on the severity of the respiratory condition and the horse's response to therapy. In case of suspension or change of treatment, it is always advisable to consult the veterinary doctor to avoid negative effects.

Treatment program

Treatment with Equistro Respadril varies depending on the respiratory pathology to be managed. In cases of acute and allergic inflammation, it can be administered daily for a period established by the veterinarian, until symptoms improve and respiratory function normalizes.

For chronic conditions such as equine asthma, the product can be used as maintenance therapy, with regular administration at recommended intervals to prevent relapses and maintain the horse's quality of life. It is essential to follow the personalized treatment plan and periodically monitor the progress of the disease.

In cases of respiratory infections, Equistro Respadril must be integrated with other specific therapies and used according to the indications of the veterinarian, who will be able to establish the overall duration of the treatment and any necessary changes during the course of treatment.

Target species

Equistro Respadril is intended exclusively for horses, with formulation and dosages specifically designed for this animal species. It is not indicated for use in other species and must only be used under veterinary supervision to ensure safety and effectiveness.

The product is suitable for both competition horses and work or companion horses, offering valid support in the treatment of respiratory problems that frequently affect this species. The responsible and conscious use of Equistro Respadril contributes to improving the respiratory well-being and quality of life of treated horses.